
Opinion|Videos|May 20, 2024
Adverse Effects Associated With JAK Inhibitors in Myelofibrosis
Naveen Pemmaraju, MD, discusses adverse effects associated with JAK inhibitors in the treatment of myelofibrosis, and the Oncology Brothers recap the entire discussion.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Lung Cancer Survival Rate Climbs to 31%, Although Screening Gaps Persist
2
FDA Approves Neladalkib in Advanced ALK+ Non–Small Cell Lung Cancer
3
Galinpepimut-S Improves Overall Survival in Phase 3 AML Maintenance Trial
4
FDA Grants Final Approval to Generic Binimetinib in BRAF-Mutant Melanoma, NSCLC
5

